Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05743283 · ClinicalTrials.gov registry record · NA
Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds
A NA study of Wound Heal, sponsored by Synedgen.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT05743283: Recruiting NA study of Wound Heal, sponsored by Synedgen.
NCT05743283 is a NA study of Wound Heal that is actively recruiting participants, run by Synedgen. The registered enrollment target is 100 participants, below the 115-participant average among 23 other Wound Heal trials with a reported enrollment target (13% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05743283, a NA study of Wound Heal, is actively recruiting participants, sponsored by Synedgen.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this interventional study is to compare SynEx Wound Cleanser with the current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating or burn wounds who participate will be asked to attend up to four study visits, use the assigned wound cleanser and complete brief surveys about their healing and well-being related to the wound healing.
Primary Outcome
The composite score is a summation of wound characteristics such size, depth, edges and undermining. Scores range from range of 13 to 60, representing wound regeneration to degeneration respectively).
Conditions Studied
Interventions
- OTHER Saline
- DEVICE SynEx Wound Cleanser
Study Locations (2)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Missouri
- Barnes Jewish Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2025-09 |
| Phase | NA |
What NCT05743283 shows while recruiting
NCT05743283 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 115-participant average among 23 other Wound Heal trials with a reported enrollment target (13% lower).
The record links to 1 condition, with Wound Heal appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT05743283 reports a single indexed study location in District of Columbia, Missouri.
Frequently Asked Questions
What is clinical trial NCT05743283 about?
NCT05743283 is a clinical study titled "Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds". The purpose of this interventional study is to compare SynEx Wound Cleanser with the current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating or burn wounds who participate will be asked to attend up to four study visits, use the assigned wound cleanser and complete ...
What is the current status of trial NCT05743283?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-12. Estimated completion is 2025-09.
What conditions does trial NCT05743283 study?
This clinical trial studies the following conditions: Wound Heal.
What interventions are being tested in trial NCT05743283?
The interventions under investigation include: Saline (OTHER), SynEx Wound Cleanser (DEVICE).
Who is sponsoring clinical trial NCT05743283?
This trial is sponsored by Synedgen, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05743283 being conducted?
This trial has 2 study locations across District of Columbia, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Heal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05743283's enrollment target sits among peer trials
100 10th of 23 higher than 14 of 23 other Wound Heal trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Heal trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Dermabrasion in Mohs: Split-Scar Trial
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
EDX110 Randomized Control Trial for Treatment of DFUs
RECRUITING · NA
-
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
RECRUITING · NA
-
Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI